The Stewards — Trusted to Build Margin, Unproven on Returns

The Stewards — Trusted to Build Margin, Unproven on Returns

The first four chapters established that Elastic finally produces cash (/chapter-1), that the moat is real but contested (/chapter-2), that demand is holding rather than bending up (/chapter-3), and that roughly 85 cents of every reported free-cash-flow dollar is still consumed by the stock-comp machine (/chapter-4). All of that converges on one question a professional investor must answer before underwriting the thesis: are the people steering this cash worth backing? The honest verdict from the record is split. On operations, management has earned its credibility — the margin turn that makes this whole case possible was self-inflicted discipline, executed on schedule. On returns to shareholders, the record is barely a year old, the first buyback was poorly timed, and the finance seat has turned over three times in the window that produced the turnaround.

A largely new team ran an old company through a hard reset

Elastic is founder-rooted but no longer founder-run. Shay Banon — who wrote the original Elasticsearch in 2010 and co-founded the company in 2012 — handed the CEO role to Ashutosh Kulkarni in January 2022, moving to Chief Technology Officer while Lead Independent Director Chetan Puttagunta took the chair [1]. Kulkarni was an inside-outsider: Elastic's Chief Product Officer at the time, but with prior runs as EVP/Chief Product Officer at McAfee and an SVP/GM at Akamai. That matters, because the strategic and financial reset that follows is his, not the founder's.

The finance function, by contrast, has been a revolving door. Long-time CFO Janesh Moorjani departed in December 2024; group VP of finance Eric Prengel stepped in as interim while the company searched [2]; and Navam Welihinda — most recently CFO of HashiCorp — joined as permanent CFO only in February 2025 [3]. Three people in the CFO chair inside eighteen months is a governance caution: the executive most responsible for capital allocation — buybacks, the balance sheet, the FY2029 targets — has been in seat barely a year, and is the one raising the margin bar (below). The bull reads continuity (Kulkarni + founder-CTO Banon); the bear reads a finance organization still settling.

The evidence that they can be trusted: a margin turn they engineered

The single strongest fact in management's favor is that the cash inflection was a choice, not an accident of the cycle. In November 2022 — Kulkarni's first full year — the company cut roughly 13% of its workforce and optimized facilities, taking a $31.3 million restructuring charge in FY2023 to "align our investments more closely with our strategic priorities" [4]. What followed is the clearest signal of discipline a software company can give: operating expense fell from 93% of revenue in FY2023 to 78% in FY2026, and the GAAP operating margin compressed from roughly -21% to -2% [5].

Source: FY2026 Annual Report (Form 10-K), MD&A — opex as % of revenue [6]; FY2022 figures from FY2023 10-K MD&A [7].

The composition matters as much as the total. The cut fell on the go-to-market and overhead lines — sales & marketing dropped from 47% to 41% of revenue and G&A from 14% to 11% — while research & development was protected, holding around 26% [8]. For a company whose moat thesis (/chapter-2) rests on out-engineering vector-database upstarts, cutting sales fat while shielding engineering is the right shape of discipline. The payoff lands on the bottom line.

Note: the four tiles read across four different rows of the query, each a distinct metric — not a time series. Sources: non-GAAP operating margin 16.4% and adjusted FCF $346M (~20% margin), FY2026 [9]; FY2029 non-GAAP operating-margin target raised to ~25%, Q4 FY2026 call [10].

Non-GAAP operating margin reached 16.4% in FY2026 and adjusted free cash flow hit $346 million at roughly a 20% margin [11]. Read against chapter 4's caution, this is the legitimate half of the story: the margin gain is real operating leverage, even if a chunk of the cash margin is still SBC-funded. Management followed through, then raised the bar — CFO Welihinda lifted the FY2029 non-GAAP operating-margin target from "above 20%" to approximately 25% and reaffirmed 20%-plus sales-led growth, putting the model on track to clear Rule of 40 (37% in FY2026) [12]. A team raising targets after it has already beaten the old ones is the behavior an owner wants to see.

M&A: disciplined tuck-ins, one expensive exception, zero write-downs

Elastic's acquisition history is the second piece of the trust case, and it is reassuring. The company has used M&A to enter adjacencies — security and observability — and most recently to buy AI capability, but it has done so in small, digestible bites and has never written any of it off: the 10-K records no goodwill impairment in FY2024, FY2025, or FY2026 [13]. Total goodwill sits at just $356 million — modest against a roughly $6 billion market value — which tells you M&A has never been the growth engine.

Sources: Endgame $234.0M, October 2019 [14]; cmdWatch/build.security/Optimyze combined $135.0M, FY2022 [15]; Jina AI (Conic AI) $43.4M, October 2025 [16].

Two observations a skeptic should hold. First, the pattern has tightened over time: the early deals were larger, while the AI-era purchase that matters most to the thesis — Jina AI, October 2025, $43.4 million in cash — was deliberately small and bolt-on, folding multi-modal embedding and reranking models into the Search AI engine (/chapter-2) rather than betting the balance sheet on a marquee acquisition [17]. That is restraint at exactly the moment the market would have rewarded a splashy AI deal. Second, the one large deal — Endgame, $234 million in October 2019 — was paid almost entirely in stock (about 2.2 million shares struck at roughly $89) [18]. It seeded the Security business that is now a third pillar, so it was strategically sound; but issuing equity to fund it was the pre-Kulkarni instinct, and it is the same dilution habit chapter 4 flags. The newer regime pays cash and keeps the checks small.

Capital allocation now: the returns chapter has just begun — and started badly

This is where the trust verdict turns guarded. For its entire public life Elastic returned nothing; it has an accumulated deficit of $732 million and, absent a one-time deferred-tax valuation-allowance release, would have posted a loss again in FY2026 (/chapter-1) [19]. The first capital-return action in company history came only in October 2025, when the board authorized a $500 million repurchase program; the company bought 4.4 million shares for $340 million at a weighted-average $76.91 in FY2026, leaving $160 million outstanding [20].

Chapter 4 dissected the mechanics — that roughly four-fifths of that spend merely sterilized SBC dilution and the first tranche was front-loaded at higher prices — so I will not re-litigate it here. The capital-allocation read is simpler and harsher: the first thing this management did with shareholder cash, it did at the wrong price. Buying back stock at a ~$77 average and watching it trade lower is exactly the value-destroying timing that a careful steward avoids. One year is too short to judge a returns philosophy, but the opening data point is a demerit, not a credit.

The capacity to do better is plainly there. The balance sheet carries roughly $1.37 billion of cash and marketable securities against a single $575 million tranche of 4.125% Senior Notes due 2029 — net cash near $0.8 billion — so the dry powder funding both buybacks and tuck-in M&A is real and cheap [21]. The question is not whether they can return capital — it is whether the still-new CFO and a board that has overseen one ill-timed tranche will deploy it with discipline. That remains unproven.

Alignment: founder skin, equity-heavy pay, an investor-grade board

The incentives broadly point the right way. At IPO, executives, directors, and 5%-plus holders together owned roughly 80% of the company, with founder Banon holding 14.8% and co-founder Steven Schuurman 21% [22]. Public-market dilution has since reduced those stakes, but the founder remains an executive director and a meaningful owner, and the board pairs operators with serious investors — chair Chetan Puttagunta of Benchmark, plus Coatue's Caryn Marooney and former Proofpoint CFO Paul Auvil. Executive pay is overwhelmingly equity rather than cash: CEO Kulkarni's FY2025 compensation was about $14.3 million, of which ~$13.0 million was stock, against a 64:1 CEO-to-median-employee ratio (per the 2025 proxy statement). That ties management's outcome to the share price — the right alignment — but it is also the source of the SBC overhang chapter 4 quantified. Alignment and dilution are, here, two faces of the same coin.

What this means for the through-line

The thesis hinges on whether Elastic can grow in the mid-to-high teens and expand margins together, with the cash accruing to owners. This chapter resolves the "who executes it" half. The operating record earns trust: a CEO who imposed a real spending reset, protected R&D while cutting go-to-market fat, hit the margin marks, and then raised the FY2029 bar; an M&A history of cheap, never-impaired tuck-ins; and a founder-anchored, investor-grade board. The capital-returns record does not yet earn it: a returns program one year old, opened with a poorly-timed buyback, run by a CFO barely a year in seat. For an owner, the takeaway is that the generation of cash is in credible hands, but the conversion of that cash into per-share value is still a promise, not a track record — and the price you pay (the next chapter's work) should reflect a management team that has proven it can build margin but not yet proven it can return capital well.